Incretins, diabetes, and bariatric surgery: a review.
Fetner
Rachel
R
Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. rachelfetner@yahoo.com
McGinty
James
J
Russell
Colleen
C
Pi-Sunyer
F Xavier
FX
Laferrère
Blandine
B
D050110:Bariatric Surgery; D015904:Biliopancreatic Diversion; D002540:Cerebral Cortex / Q000378:metabolism*; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000503:physiopathology* / Q000601:surgery; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism* / Q000502:physiology; D015391:Gastroplasty; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D009767:Obesity, Morbid / Q000453:epidemiology / Q000503:physiopathology* / Q000601:surgery; D011184:Postoperative Period; D012528:Satiety Response
D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1